UNM
65
-7
RIG
40
2
APA
53
5
OI
47
-11
GIS
58
-2
IRM
41
10
ADP
54
-4
IP
28
-3
CRM
70
18
EFX
54
2
CNX
49
3
EMN
56
-2
MA
55
4
WHR
50
-5
URI
46
3
CAG
41
-5
PNW
53
-3
HPE
75
7
DUK
52
-5
EOG
33
-3
UNM
65
-7
RIG
40
2
APA
53
5
OI
47
-11
GIS
58
-2
IRM
41
10
ADP
54
-4
IP
28
-3
CRM
70
18
EFX
54
2
CNX
49
3
EMN
56
-2
MA
55
4
WHR
50
-5
URI
46
3
CAG
41
-5
PNW
53
-3
HPE
75
7
DUK
52
-5
EOG
33
-3
Financhill
Back

Immunovant, Inc. Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
45

IMVT
Immunovant, Inc.

Last Price:
$26.66
Seasonality Move:
-32.5%

7 Day Trial

ALL ACCESS PASS

$ 7

Immunovant, Inc. Stock Forecast

  • Over the next 52 weeks, Immunovant, Inc. has on average historically risen by 66.7% based on the past 6 years of stock performance.
  • Immunovant, Inc. has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is Immunovant, Inc. Stock Undervalued?
    The current Immunovant, Inc. [IMVT] share price is $26.68. The Score for IMVT is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • IMVT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Immunovant, Inc. Stock Go Up Next Year?

  • Over the next 52 weeks, Immunovant, Inc. has on average historically risen by 66.7% based on the past 6 years of stock performance.

Immunovant, Inc. Stock Rating

Sell
45
Immunovant, Inc. (IMVT) is a Sell

Is Immunovant, Inc. overpriced?

  • Immunovant, Inc. has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Immunovant, Inc. Stock Price History

Is IMVT stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IMVT is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
immunovant.com

52-Week Data

52-Week High:
27.69
52-Week Low:
12.72

Prediction Charts

Market Cap:
4.7B
Price in USD:
26.68
Volume:
3.4M
Beta:
0.77

Technical Analysis

SMA50:
22.54
SMA100:
19.14
SMA200:
17.71
52-Wk Change:
3.98%

Stock Predictions

  • Is Immunovant, Inc. stock public?
    Yes, Immunovant, Inc. is a publicly traded company.
  • What is the Immunovant, Inc. stock quote today?
    The Immunovant, Inc. stock price is 26.68 USD today.
  • How to buy Immunovant, Inc. stock online?
    You can buy Immunovant, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-2 22.90 22.02 23.06 21.93
Dec-3 22.22 22.71 23.06 22.10
Dec-4 22.55 22.91 23.31 22.29
Dec-5 22.89 22.84 23.12 22.58
Dec-8 23.23 23.17 23.49 22.96
Dec-9 23.33 22.76 23.51 22.70
Dec-10 22.66 23.56 23.65 22.33
Dec-11 23.46 24.81 27.06 22.78
Dec-12 24.90 26.42 26.50 24.47
Dec-15 26.73 26.00 27.29 25.57
Dec-16 26.08 26.61 26.91 25.69
Dec-17 26.70 26.98 27.69 26.50
Dec-18 27.01 26.18 27.54 25.84
Dec-19 26.44 26.68 27.34 26.37

Immunovant, Inc. Earnings

Immunovant, Inc. Earnings Report: Per Share Immunovant, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Immunovant, Inc. Forecast Revenue Growth

Immunovant, Inc. Stock Analysis: Historical quarterly revenues per share for Immunovant, Inc. and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.13 per share, and a decrease next year of $0.05 per share.

* Immunovant, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.